Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limitedverified

LVCLF

Price:

$0.0049

Market Cap:

$24.53M

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient for the of treatment for dementia, including Alzheimer's disease; NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient to treat cardiovascular disease, including hypertension. It is also developing AlgaraeOS in partnership with the U...[Read more]

Industry

Biotechnology

IPO Date

2010-06-01

Stock Exchange

OTC

Ticker

LVCLF

The PE Ratio as of December 2025 (TTM) for Algorae Pharmaceuticals Limited (LVCLF) is -0.24

According to Algorae Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.24. This represents a change of -96.03% compared to the average of -6.05 of the last 4 quarters.

Algorae Pharmaceuticals Limited (LVCLF) Historical PE Ratio (quarterly & annually)

How has LVCLF PE Ratio performed in the past?

The mean historical PE Ratio of Algorae Pharmaceuticals Limited over the last ten years is -11.27. The current -0.24 PE Ratio has changed 112.88% with respect to the historical average. Over the past ten years (40 quarters), LVCLF's PE Ratio was at its highest in in the June 2018 quarter at 2.28. The PE Ratio was at its lowest in in the December 2012 quarter at -17.15.

Quarterly (TTM)
Annual

Average

-11.27

Median

-8.54

Minimum

-40.42

Maximum

-3.03

Algorae Pharmaceuticals Limited (LVCLF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Algorae Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 274.68%

Maximum Annual PE Ratio = -3.03

Minimum Annual Increase = -88.70%

Minimum Annual PE Ratio = -40.42

Quarterly (TTM)
Annual
YearPE RatioChange
2024-12.3228.49%
2023-9.59164.54%
2022-3.62-27.15%
2021-4.97-33.69%
2020-7.5064.25%
2019-4.57-88.70%
2018-40.42162.86%
2017-15.3835.48%
2016-11.35274.68%
2015-3.036.44%

Algorae Pharmaceuticals Limited (LVCLF) Average PE Ratio

How has LVCLF PE Ratio performed in the past?

The current PE Ratio of Algorae Pharmaceuticals Limited (LVCLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-8.51

5-year avg

-7.60

10-year avg

-11.27

Algorae Pharmaceuticals Limited (LVCLF) PE Ratio vs. Peers

How is LVCLF’s PE Ratio compared to its peers?

Algorae Pharmaceuticals Limited’s PE Ratio is less than HOOKIPA Pharma Inc. (-0.15), less than Oxford BioDynamics Plc (-0.17), greater than Devonian Health Group Inc. (-3.39), greater than EOM Pharmaceuticals Holdings, Inc. (-12.17), greater than Nymox Pharmaceutical Corporation (-3.12), greater than Hemostemix Inc. (-2.39), greater than Sirona Biochem Corp. (-0.70), less than LianBio (4.68), less than Valeo Pharma Inc. (-0.00), less than Propanc Biopharma, Inc. (-0.16),

Build a custom stock screener for Algorae Pharmaceuticals Limited (LVCLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Algorae Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Algorae Pharmaceuticals Limited (LVCLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Algorae Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Algorae Pharmaceuticals Limited's PE Ratio?

How is the PE Ratio calculated for Algorae Pharmaceuticals Limited (LVCLF)?

What is the highest PE Ratio for Algorae Pharmaceuticals Limited (LVCLF)?

What is the 3-year average PE Ratio for Algorae Pharmaceuticals Limited (LVCLF)?

What is the 5-year average PE Ratio for Algorae Pharmaceuticals Limited (LVCLF)?

How does the current PE Ratio for Algorae Pharmaceuticals Limited (LVCLF) compare to its historical average?